Broadcom Has Just Crashed - I'm Buying This Dip (Rating Upgrade)

AVGO has fallen more than 12%, but the article argues the selloff is overdone because the expected gross margin decline to 74% is tied to a higher AI revenue mix rather than a structural problem. Management is portrayed as confident that growth remains intact, and the author sees double-digit long-term total return potential. The piece is mainly analyst-style commentary on fundamentals and sentiment rather than new company-reported data.

Analysis

The market is treating a margin mix shift as if it were a deterioration in the franchise, which is usually the wrong inference for a platform business with pricing power and embedded switching costs. If AI-related revenue is structurally higher and lower-margin at first, the near-term optics can compress multiples, but that often creates a better entry point for long-duration holders because the earnings stream becomes more durable, not less. The key second-order effect is that slower gross margin expansion can actually reduce expectations for aggressive reinvestment risk, making free cash flow quality the more important metric than headline GM.

The real losers are likely the names that were implicitly priced off the assumption AVGO’s AI exposure would be pure-margin uplift. A lower take-rate from AI hardware in the mix can pressure sentiment across adjacent semiconductor infrastructure names that rely on the same “AI equals instant margin expansion” narrative. On the supply-chain side, any vendor dependent on AVGO’s demand elasticity may see less follow-through if buyers start discounting the sustainability of AI capex, but that is a positioning issue over months, not a demand-collapse signal over days.

The contrarian view is that the selloff is probably overdone relative to the actual earnings power trajectory. A 12% reset often already bakes in a meaningful portion of the worst-case interpretation, and that can be reversed if management reiterates that AI mix is a volume lever rather than a structural profitability problem. The catalyst window is the next 1-2 quarters: any evidence that incremental AI revenue translates into better operating leverage, stronger backlog, or raised guidance on cash flow conversion would force shorts to cover quickly.

From a risk standpoint, the main tail risk is that the market is not wrong about the mix shift, just early: if AI product economics prove persistently lower and legacy businesses fail to reaccelerate, multiple compression can persist for several quarters. But if the earnings call or subsequent guidance confirms margin normalization in FY26, the stock can re-rate sharply because the current move has created room for both multiple expansion and fundamentals to improve. This is a classic time-arbitrage setup: short-term optics versus medium-term cash generation.

Key Decisions for Investors

• Buy AVGO into weakness over the next 1-3 trading sessions; use a staggered entry and target a 3-6 month hold. Risk/reward favors upside if the market is merely de-rating the mix rather than impairing the franchise.
• For more controlled risk, buy 3-6 month AVGO call spreads ~10-15% above spot. This captures a normalization trade while defining downside if margin concerns persist for another quarter.
• Pair trade: long AVGO / short a more sentiment-sensitive AI infrastructure name over 1-2 months if you expect the market to reprice margin quality rather than AI demand itself. The spread should benefit if investors rotate from narrative to cash flow.
• If already long AVGO, consider adding only on confirmation of stable forward guidance; otherwise hedge with short-dated puts through the next earnings/guidance event to protect against a second leg down from margin headline risk.
• Set a tactical review trigger after the next quarterly update: if management does not reaccelerate confidence around operating leverage within 1 quarter, reduce exposure and treat this as a longer-duration valuation reset.